Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34,701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer.
Majeed S, Aparnathi MK, Nixon KCJ, Venkatasubramanian V, Rahman F, Song L, Weiss J, Barayan R, Sugumar V, Barghout SH, Pearson JD, Bremner R, Schimmer AD, Tsao MS, Liu G, Lok BH. Majeed S, et al. Among authors: liu g. Clin Cancer Res. 2022 May 2;28(9):1966-1978. doi: 10.1158/1078-0432.CCR-21-0344. Clin Cancer Res. 2022. PMID: 35165102 Free PMC article.
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C, Xu W, Marshall AL, Heist RS, Wain JC, Lynch TJ Jr, Christiani DC, Liu G. Cescon DW, et al. Among authors: liu g. Clin Cancer Res. 2009 May 1;15(9):3103-9. doi: 10.1158/1078-0432.CCR-08-3120. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383811 Free PMC article.
Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
Bradbury PA, Zhai R, Ma C, Xu W, Hopkins J, Kulke MJ, Asomaning K, Wang Z, Su L, Heist RS, Lynch TJ, Wain JC, Christiani D, Liu G. Bradbury PA, et al. Among authors: liu g. Clin Cancer Res. 2009 Jul 15;15(14):4680-5. doi: 10.1158/1078-0432.CCR-09-0192. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584152 Free PMC article.
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer.
Lara-Guerra H, Waddell TK, Salvarrey MA, Joshua AM, Chung CT, Paul N, Boerner S, Sakurada A, Ludkovski O, Ma C, Squire J, Liu G, Shepherd FA, Tsao MS, Leighl NB. Lara-Guerra H, et al. Among authors: liu g. J Clin Oncol. 2009 Dec 20;27(36):6229-36. doi: 10.1200/JCO.2009.22.3370. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884551 Clinical Trial.
Pharmacogenetic and germline prognostic markers of lung cancer.
Horgan AM, Yang B, Azad AK, Amir E, John T, Cescon DW, Wheatley-Price P, Hung RJ, Shepherd FA, Liu G. Horgan AM, et al. Among authors: liu g. J Thorac Oncol. 2011 Feb;6(2):296-304. doi: 10.1097/JTO.0b013e3181ffe909. J Thorac Oncol. 2011. PMID: 21206385 Free article.
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
Coate LE, Massey C, Hope A, Sacher A, Barrett K, Pierre A, Leighl N, Brade A, de Perrot M, Waddell T, Liu G, Feld R, Burkes R, Cho BC, Darling G, Sun A, Keshavjee S, Bezjak A, Shepherd FA. Coate LE, et al. Among authors: liu g. J Thorac Oncol. 2011 Mar;6(3):537-44. doi: 10.1097/JTO.0b013e31820b8b9b. J Thorac Oncol. 2011. PMID: 21258243 Free article.
34,701 results
You have reached the last available page of results. Please see the User Guide for more information.